Post-Trial Access to ATH434 for Patients With Multiple System Atrophy

Available (expanded access)

Conditions studied: Multiple System Atrophy

In brief

This multicenter post-trial access program is designed to provide ATH434 orally BID to eligible patients who completed Phase 2 studies ATH434-201 or ATH434-202, and who may benefit from this treatment according to the evaluation by their treating physicians.

Key facts

Study ID

NCT07531433

Run by

Alterity Therapeutics

Last updated by the study team

2026-04-15

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Completed Alterity protocol ATH434-201 or ATH434-202
• Expected to benefit from treatment from treatment with ATH434, in the opinion of the treating physician

You may not qualify if…

• Discontinued prior ATH434 treatment (ATH434-201 or ATH434-202) for any reason
• Significant medical or psychiatric condition that may decrease the benefit-risk ratio of participation in this program to an unacceptable level, as per the treating physician's opinion

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.